Medinno Inc. is developing Thrombin pre-conditioned Wharton’s Jelly-derived Mesenchymal Stem Cells (HIEstem) for brain diseases of new borns, such as hypoxic ischemic encephalopathy (HIE) and intraventricular hemorrhage (IVH). Adult Human Neural Stem Cells (ahNSCs) are for adult brain diseases including spinal cord injury (SCI) and stroke. Medinno Inc. is continuously developing new cell therapeutics for various brain diseases by scientific research.
Division | Pipeline | Project Code | Indication | Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|---|---|---|---|
Stem Cell Therapeutics |
HIEstem | MS1901 | Hypoxic Ischemic Encephalopathy |
|
|||
MS2001 | Intraventricular Hemorrhage |
|
|||||
Adult Human Neural Stem Cell | MS2002 | Spinal Cord Injury |
|
||||
MS2101 | Stroke |
|
|||||
Gene therapy using Stem Cell |
Multiple Sclerosis |
|
|||||
Brain Tumor |
|
Division | Pipeline | Project Code | Indication |
---|---|---|---|
Stem Cell Therapeutics |
HIEstem | MS1901 | Hypoxic-Ischemic Encephalopathy |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|
Division | Pipeline | Project Code | Indication |
---|---|---|---|
Stem Cell Therapeutics |
HIEstem | MS2001 | Intraventricular Hemorrhage |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|
Division | Pipeline | Project Code | Indication |
---|---|---|---|
Stem Cell Therapeutics |
Adult Human Neural Stem Cell | MS2002 | Spinal Cord Injury |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|
Division | Pipeline | Project Code | Indication |
---|---|---|---|
Stem Cell Therapeutics |
Adult Human Neural Stem Cell | MS2101 | Stroke |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|
Division | Project Code | Indication |
---|---|---|
Stem Cell Gene Therapeutics |
ㅡ | Multiple sclerosis |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|
Division | Project Code | Indication |
---|---|---|
Stem Cell Gene Therapeutics |
ㅡ | Brain Tumor |
Non-clinical | Phase Ⅰ | Phase Ⅱ | BLA |
---|---|---|---|
|